Nippon Shinyaku
4516.TSE
23.05 USD
-0.21
-0.90%
n
Overview
Last close
23.05 usd
Market cap
1.55B usd
52 week high
29.10 usd
52 week low
19.26 usd
Target price
23.89 usd
Valuation
P/E
7.6694
Forward P/E
12.9199
Price/Sales
1.5269
Price/Book Value
0.9142
Enterprise Value
1.09B usd
EV/Revenue
1.0692
EV/EBITDA
3.8649
Key financials
Revenue TTM
1.02B usd
Gross Profit TTM
693.53M usd
EBITDA TTM
285.65M usd
Earnings per Share
3.02 usd
Dividend
0.39 usd
Total assets
2.01B usd
Net debt
N/A usd
About
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and RGX-121 for the treatment of mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
- Symbol4516.TSE
- ExchangeTSE
- IsinJP3717600005
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEO
- HeadquarterKyoto
- Web sitehttps://www.nippon-shinyaku.co.jp
